Molecular characterization of rotavirus strains detected during a clinical trial of a human rotavirus vaccine in Blantyre, Malawi

Vaccine

Volumn 30, Issue SUPPL. 1, 2012, Pages

  Nakagomi, Toyoko ^a,b   Nakagomi, Osamu ^a,b   Dove, Winifred ^b   Doan, Yen Hai ^a   Witte, Desiree ^b,c   Ngwira, Bagrey ^c   Todd, Stacy ^b   Duncan Steele, A ^d   Neuzil, Kathleen M ^d   Cunliffe, Nigel A ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF MALAWI   (Malawi)

^d PATH   (United States)

Author keywords

Genogroup; Genotype; Rotavirus; Strain diversity; Vaccine

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CONTROLLED STUDY; FECES ANALYSIS; GENOTYPE; INFECTION PREVENTION; MALAWI; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RNA RNA HYBRIDIZATION; ROTAVIRUS; UNINDEXED SEQUENCE; VIRUS CULTURE; VIRUS STRAIN;

CLUSTER ANALYSIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FECES; GENES, VIRAL; GENETIC VARIATION; GENOTYPE; HUMANS; MALAWI; MOLECULAR SEQUENCE DATA; NUCLEIC ACID HYBRIDIZATION; PHYLOGENY; RNA, VIRAL; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEQUENCE ANALYSIS, DNA;

EID: 84859945582     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.119     Document Type: Article

References (40)

1. Parashar U.D., Burton A., Lanata C., Boschi-Pinto C., Shibuya K., Steele D., et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009, 200:S9-S15.
2. Naghipour M., Nakagomi T., Nakagomi O. Issues with reducing the rotavirus-associated mortality by vaccination in developing countries. Vaccine 2008, 26:3236-3241.
3. Cunliffe N., Nakagomi O. Introduction of rotavirus vaccines in developing countries: remaining challenges. Ann Trop Paediatr 2007, 27:157-167.
4. Ruiz-Palacios G.M., Pérez-Schael I., Velázquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354:11-22.
5. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354:23-33.
6. World Health Organization Conclusions and recommendations from the Immunization Strategic Advisory Group. Wkly Epidemiol Rec 2006, 81:1-12.
7. World Health Organization The WHO position paper on rotavirus vaccines. Wkly Epidemiol Rec 2007, 82:285-296.
8. Madhi S.A., Cunliffe N.A., Steele A.D., Witte D., Kirsten M., Louw C., et al. Impact of human rotavirus vaccine on severe gastroenteritis in African infants. N Engl J Med 2010, 362:289-298.
9. World Health Organization Meeting of the immunization Strategic Advisory Group of Experts, April 2009 - conclusions and recommendations. Wkly Epidemiol Rec 2009, 84:220-236.
10. Gentsch J.R., Laird A.R., Bielfelt B., Griffin D.D., Banyai K., Ramachandran M., et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005, 192:S146-S159.
11. Santos N., Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005, 15:29-56.
12. Matthijnssens J., Ciarlet M., Rahman M., Attoui H., Bányai K., Estes M.K., et al. Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol 2008, 153:1621-1629.
13. Cunliffe N.A., Gondwe J.S., Broadhead R.L., Molyneux M.E., Woods P.A., Bresee J.S., et al. Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains. J Med Virol 1999, 57:308-312.
14. Cunliffe N.A., Gentsch J.R., Kirkwood C.D., Gondwe J.S., Dove W., Nakagomi O., et al. Molecular and serologic characterization of novel serotype G8 human rotavirus strains detected in Blantyre, Malawi. Virology 2000, 274:309-320.
15. Cunliffe N.A., Gondwe J.S., Graham S.M., Thindwa B.D., Dove W., Broadhead R.L., et al. Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999. J Clin Microbiol 2001, 39:836-843.
16. Cunliffe N.A., Ngwira B.M., Dove W., Thindwa B.D., Turner A.M., Broadhead R.L., et al. Epidemiology of rotavirus infection in children in Blantyre, Malawi, 1997-2007. J Infect Dis 2010, 202:S168-S174.
17. Page N., Esona M., Seheri M., Nyangao J., Bos P., Mwenda J., et al. Characterization of genotype G8 strains from Malawi, Kenya, and South Africa. J Med Virol 2010, 82:2073-2081.
18. Nakagomi O., Nakagomi T., Akatani K., Ikegami N. Identification of rotavirus genogroups by RNA-RNA hybridization. Mol Cell Probes 1989, 3:251-261.
19. Nakagomi O., Nakagomi T. Molecular evidence for naturally occurring single VP7 gene substitution reassortant between human rotaviruses belonging to two different genogroups. Arch Virol 1991, 119:67-81.
20. Nakagomi O., Nakagomi T. Genetic diversity and similarity among mammalian rotaviruses in relation to interspecies transmission of rotavirus. Arch Virol 1991, 120:43-55.
21. van Doorn L.J., Kleter B., Hoefnagel E., Stainier I., Poliszczak A., Colau B., et al. Detection and genotyping of human rotavirus VP4 and VP7 genes by reverse transcriptase PCR and reverse hybridization. J Clin Microbiol 2009, 47:2704-2712.
22. Kheyami A.M., Nakagomi T., Nakagomi O., Dove W., Hart C.A., Cunliffe N.A. Molecular epidemiology of rotavirus diarrhea among children in Saudi Arabia: first detection of G9 and G12 Strains. J Clin Microbiol 2008, 46:1185-1191.
23. Estes M., Kapikian A. Fields virology 2007, 1917-1974. Rotaviruses, Kluwer Health/Lippincott, Williams and Wilkins, Philadelphia. fifth ed. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (Eds.).
24. Gouvea V., Glass R.I., Woods P., Taniguchi K., Clark H.F., Forrester B., et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990, 28:276-282.
25. Gentsch J.R., Glass R.I., Woods P., Gouvea V., Gorziglia M., Flores J., et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992, 30:1365-1373.
26. Matthijnssens J., Ciarlet M., Heiman E., Arijs I., Delbeke T., McDonald S.M., et al. Full genome-based classification of rotaviruses reveals common origin between human Wa-like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol 2008, 82:3204-3219.
27. Horie Y., Masamune O., Nakagomi O. Three major alleles of rotavirus NSP4 proteins identified by sequence analysis. J Gen Virol 1997, 78:2341-2346.
28. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596-1599.
29. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987, 4:406-425.
30. Kutsuzawa T., Konno T., Suzuki H., Kapikian A.Z., Ebina T., Ishida N. Isolation of human rotavirus subgroups 1 and 2 in cell culture. J Clin Microbiol 1982, 16:727-730.
31. Todd S., Page N.A., Steele A.D., Peenze I., Cunliffe N.A. Rotavirus strain types circulating in Africa: review of studies published from 1997 to 2006. J Infect Dis 2010, 202:S34-S42.
32. Soares-Weiser K., MacLehose H., Ben-Aharon I., Goldberg E., Pitan F., Cunliffe N. Vaccines for preventing rotavirus diarrhoea. Part 1. Vaccines approved for use. Cochrane Database Syst Rev 2010 May 12, 5:CD008521.
33. Tate J.E., Patel M.M., Steele A.D., Gentsch J.R., Payne D.C., Cortese M.M., et al. Global impact of rotavirus vaccines. Exp Rev Vaccines 2010, 9:395-407.
34. De Vos B., Han H.H., Bouckenooghe A., Debrus S., Gillard P., Ward R., et al. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials. Pediatr Infect Dis J 2009, 28:261-266.
35. Vesikari T., Karvonen A., Prymula R., Schuster V., Tejedor J.C., Cohen R., et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2years of life in European infants: randomised, double-blind controlled study. Lancet 2007, 370:1757-1763.
36. Correia J.B., Patel M.M., Nakagomi O., Montenegro F.M.U., Germano E.M., Correia N.B., et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhoea caused by serotypically-unrelated G2P[4] strains in Brazil. J Infect Dis 2010, 201:363-369.
37. Ward R.L. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. Viral Immunol 2003, 16:17-24.
38. Ward R.L. Rotavirus vaccines: how they work or don't work. Expert Rev Mol Med 2008, 10:e5.
39. Ward R.L. Mechanisms of protection against rotavirus infection and disease. Pediatr Infect Dis J 2009, 28:S57-S59.
40. Ward R.L., Clark H.F., Offit P.A. Influence of potential protective mechanisms on the development of live rotavirus vaccines. J Infect Dis 2010, 202:S72-S79.